Sulfonyl containing compounds as cysteine protease inhibitors
US7893093B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 22, 2006 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Sep 27, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.